Status:
COMPLETED
Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients
Lead Sponsor:
Oslo University Hospital
Conditions:
Melanoma
Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective randomized non-inferiority study is designed to compare the rate and severity of complications after axillary and inguinal lymph node dissection in stage III melanoma patients in a st...
Detailed Description
Consecutive stage III melanoma patients 18 years or older referred to our institution for axillary or inguinal lymph node dissection is eligible for inclusion of the study. A bipolar vessel sealing de...
Eligibility Criteria
Inclusion
- stage III melanoma patients with confirmed metastases to lymph nodes in axilla or groin
Exclusion
- unable to follow instructions or provide an informed written consent
Key Trial Info
Start Date :
May 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04680182
Start Date
May 11 2018
End Date
September 1 2022
Last Update
September 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway